Monica Dougherty, PharmD, BCACP, explains how the 2026 GOLD guideline updates use blood eosinophil counts to guide biologic therapy decisions for patients with COPD.
Monica Dougherty, PharmD, BCACP
Advertisement
Articles by Monica Dougherty, PharmD, BCACP
New AAAAI data spotlight oral remibrutinib for CSU, next-generation peanut allergy therapies, infant microbiome prevention, and GLP‑1 receptor agonists linked to fewer asthma flares.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
As Measles Cases Surge, Pharmacists Are Stepping Up to Close the Vaccination Gap
2
American Regent Recalls 3 Epinephrine Injection Lots Over Particulate Matter, Sterility Concerns
3
High-Dose Influenza Vaccine Lowers Hospitalization Risk in Older Adults With Chronic Lung Disease
4
Building a Strong Financial Foundation: 5 Pillars Every Pharmacist Needs Before Optimizing Their Financial Plan
5